Markus P. Ghadimi

934 total citations
28 papers, 665 citations indexed

About

Markus P. Ghadimi is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Markus P. Ghadimi has authored 28 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Markus P. Ghadimi's work include Sarcoma Diagnosis and Treatment (19 papers), Cardiac tumors and thrombi (6 papers) and Esophageal and GI Pathology (5 papers). Markus P. Ghadimi is often cited by papers focused on Sarcoma Diagnosis and Treatment (19 papers), Cardiac tumors and thrombi (6 papers) and Esophageal and GI Pathology (5 papers). Markus P. Ghadimi collaborates with scholars based in Germany, United States and Netherlands. Markus P. Ghadimi's co-authors include Alexander J. Lazar, Dina Lev, Aviad Hoffman, Raphael E. Pollock, Keila E. Torres, Chiara Colombo, Tingsheng Peng, Eric D. Young, Svetlana Bolshakov and Elizabeth G. Demicco and has published in prestigious journals such as Cancer, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Markus P. Ghadimi

27 papers receiving 655 citations

Peers

Markus P. Ghadimi
Markus P. Ghadimi
Citations per year, relative to Markus P. Ghadimi Markus P. Ghadimi (= 1×) peers Hanna Koseła-Paterczyk

Countries citing papers authored by Markus P. Ghadimi

Since Specialization
Citations

This map shows the geographic impact of Markus P. Ghadimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus P. Ghadimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus P. Ghadimi more than expected).

Fields of papers citing papers by Markus P. Ghadimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus P. Ghadimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus P. Ghadimi. The network helps show where Markus P. Ghadimi may publish in the future.

Co-authorship network of co-authors of Markus P. Ghadimi

This figure shows the co-authorship network connecting the top 25 collaborators of Markus P. Ghadimi. A scholar is included among the top collaborators of Markus P. Ghadimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus P. Ghadimi. Markus P. Ghadimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Damanakis, Alexander, Florian Gebauer, Hans Schlößer, et al.. (2023). Combined regression score predicts outcome after neoadjuvant treatment of oesophageal cancer. British Journal of Cancer. 128(11). 2025–2035. 4 indexed citations
2.
Vay, Christian, Levent Dizdar, Iréne Esposito, et al.. (2021). Targeting abundant survivin expression in liposarcoma: subtype dependent therapy responses to YM155 treatment. Journal of Cancer Research and Clinical Oncology. 148(3). 633–645. 3 indexed citations
3.
Peters, Franziska, Britta Fiebig, Pontus Lundberg, et al.. (2021). Detection of the germline KIT S476I mutation in a kindred with familial mastocytosis associated with gastrointestinal stromal tumors. The Journal of Allergy and Clinical Immunology In Practice. 9(5). 2123–2125.e1. 8 indexed citations
4.
Schmidt, Thomas, Markus P. Ghadimi, Hans F. Fuchs, & Christiane J. Bruns. (2021). Chirurgische und interdisziplinäre Therapie gastrointestinaler Stromatumoren. Der Chirurg. 93(1). 27–33. 1 indexed citations
5.
Ghadimi, Markus P. & Christiane J. Bruns. (2019). Systematische Chirurgie retroperitonealer Sarkome. Der Chirurg. 90(6). 447–456. 1 indexed citations
6.
Ghadimi, Markus P. & Christiane J. Bruns. (2019). Systematische Chirurgie retroperitonealer Sarkome: Bildgestützte Planung des Resektionsausmaßes. Chirurg. 90(6). 447–456.
7.
Buchner, Denise, et al.. (2018). First reported case of a collision tumor composed of pancreatic adenocarcinoma and retroperitoneal liposarcoma: a case report. BMC Cancer. 18(1). 1243–1243. 4 indexed citations
8.
Mersch, Sabrina, Jasmin Riemer, Markus P. Ghadimi, et al.. (2015). Peritoneal sarcomatosis: site of origin for the establishment of an in vitro and in vivo cell line model to study therapeutic resistance in dedifferentiated liposarcoma. Tumor Biology. 37(2). 2341–2351. 3 indexed citations
9.
Ghadimi, Markus P., Alexander Rehders, & Wolfram Trudo Knoefel. (2014). Multimodales Management bei Weichteilsarkomen des Stammes und der Extremitäten. Der Chirurg. 85(5). 378–382. 1 indexed citations
10.
Tseng, William W., John E. Madewell, Wei Wei, et al.. (2014). Locoregional Disease Patterns in Well-Differentiated and Dedifferentiated Retroperitoneal Liposarcoma: Implications for the Extent of Resection?. Annals of Surgical Oncology. 21(7). 2136–2143. 84 indexed citations
11.
Ghadimi, Markus P., Gonzalo Lopez, Keila E. Torres, et al.. (2012). Targeting the PI3K/mTOR Axis, Alone and in Combination with Autophagy Blockade, for the Treatment of Malignant Peripheral Nerve Sheath Tumors. Molecular Cancer Therapeutics. 11(8). 1758–1769. 42 indexed citations
12.
Ghadimi, Markus P., Eric D. Young, Roman Belousov, et al.. (2012). Survivin Is a Viable Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors. Clinical Cancer Research. 18(9). 2545–2557. 36 indexed citations
13.
Xie, Xianbiao, Markus P. Ghadimi, Eric D. Young, et al.. (2011). Combining EGFR and mTOR Blockade for the Treatment of Epithelioid Sarcoma. Clinical Cancer Research. 17(18). 5901–5912. 34 indexed citations
14.
Torres, Keila E., Quansheng Zhu, Katelynn Bill, et al.. (2011). Activated MET Is a Molecular Prognosticator and Potential Therapeutic Target for Malignant Peripheral Nerve Sheath Tumors. Clinical Cancer Research. 17(12). 3943–3955. 74 indexed citations
15.
Colombo, Chiara, Chad J. Creighton, Markus P. Ghadimi, et al.. (2011). Increased midkine expression correlates with desmoid tumour recurrence: a potential biomarker and therapeutic target. The Journal of Pathology. 225(4). 574–582. 18 indexed citations
16.
Demicco, Elizabeth G., Keila E. Torres, Markus P. Ghadimi, et al.. (2011). Involvement of the PI3K/Akt pathway in myxoid/round cell liposarcoma. Modern Pathology. 25(2). 212–221. 69 indexed citations
17.
Lahat, Guy, Pingyu Zhang, Quan-Sheng Zhu, et al.. (2011). The expression of c-Met pathway components in unclassified pleomorphic sarcoma/malignant fibrous histiocytoma (UPS/MFH): a tissue microarray study. Histopathology. 59(3). 556–561. 22 indexed citations
18.
Ghadimi, Markus P., Tariq Al‐Zaid, John E. Madewell, et al.. (2011). Diagnosis, Management, and Outcome of Patients with Dedifferentiated Liposarcoma Systemic Metastasis. Annals of Surgical Oncology. 18(13). 3762–3770. 56 indexed citations
19.
Ghadimi, Markus P., Ping Liu, Tingsheng Peng, et al.. (2011). Pleomorphic liposarcoma. Cancer. 117(23). 5359–5369. 80 indexed citations
20.
Fritscher‐Ravens, Annette, Tamzin Cuming, Claus Ferdinand Eisenberger, et al.. (2010). Randomized comparative long-term survival study of endoscopic and thoracoscopic esophageal wall repair after NOTES mediastinoscopy in healthy and compromised animals. Endoscopy. 42(6). 468–474. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026